Literature DB >> 15985539

Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.

Maxim I Lutskiy1, Diana S Beardsley, Fred S Rosen, Eileen Remold-O'Donnell.   

Abstract

Rare cases of somatic mosaicism resulting from reversion of inherited mutations can lead to the attenuation of blood-cell disorders, including Wiskott-Aldrich syndrome (WAS). The impact of the revertant hematopoietic stem or progenitor cells, particularly their representation in blood-cell populations, is of interest because it predicts the outcome of gene therapy. Here we report an 8-year-old patient with WAS caused by a single nucleotide insertion in the WASP gene that abrogates protein expression. The patient nonetheless had mild disease. We found reversion of the mutation in a fraction of patient lymphocytes. Forty percent of natural killer (NK) cells expressed Wiskott-Aldrich syndrome protein (WASP), and NK cells contained both mutated and revertant (normal) sequences. WASP was not expressed in patient T or B cells; T cells contained only the mutated sequence. The selective advantage of WASP+ NK cells was also demonstrated for carrier females. The enrichment of WASP+-revertant NK cells indicates that WASP provides a selective advantage in this lineage and predicts the success of gene therapy for reconstituting the NK-cell compartment. The importance of reconstituting the NK-cell lineage is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985539      PMCID: PMC1895310          DOI: 10.1182/blood-2004-12-4724

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

Authors:  T Wada; S H Schurman; M Otsu; E K Garabedian; H D Ochs; D L Nelson; F Candotti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes.

Authors:  T Ariga; M Yamada; Y Sakiyama; O Tatsuzawa
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

3.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

Authors:  J S Miller; V McCullar
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

4.  Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome.

Authors:  T Ariga; T Kondoh; K Yamaguchi; M Yamada; S Sasaki; D L Nelson; H Ikeda; K Kobayashi; H Moriuchi; Y Sakiyama
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.

Authors:  E Remold-O'Donnell; J Cooley; A Shcherbina; T L Hagemann; S P Kwan; D M Kenney; F S Rosen
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

7.  NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

Authors:  Christophe Borg; Abdelali Jalil; Diego Laderach; Kouji Maruyama; Hiro Wakasugi; Sabine Charrier; Bernhard Ryffel; Alessandra Cambi; Carl Figdor; William Vainchenker; Anne Galy; Anne Caignard; Laurence Zitvogel
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

8.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Authors:  Yinzhu Jin; Cinzia Mazza; Jacinda R Christie; Silvia Giliani; Maurilia Fiorini; Patrizia Mella; Francesca Gandellini; Donn M Stewart; Qili Zhu; David L Nelson; Luigi D Notarangelo; Hans D Ochs
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

Review 9.  Mechanisms of WASp-mediated hematologic and immunologic disease.

Authors:  Siobhan Burns; Giles O Cory; William Vainchenker; Adrian J Thrasher
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

10.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  12 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

2.  Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells.

Authors:  Alexander Astrakhan; Hans D Ochs; David J Rawlings
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 3.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

4.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

5.  Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.

Authors:  Brian R Davis; Fabio Candotti
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006.

Authors:  Donn M Stewart; Fabio Candotti; David L Nelson
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

Review 7.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

Review 8.  Development of lentiviral gene therapy for Wiskott Aldrich syndrome.

Authors:  Anne Galy; Maria-Grazia Roncarolo; Adrian J Thrasher
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

Review 9.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

Review 10.  WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.

Authors:  Elad Noy; Sophia Fried; Omri Matalon; Mira Barda-Saad
Journal:  Int J Mol Sci       Date:  2012-06-21       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.